Additionally, Furthermore, miRNA-5119 has been identified as a potential regulator of PD-L1 in DCs, and its mimic-engineered DC vaccines have shown promising results in enhancing anti-tumor immune responses in a mouse model of breast cancer (54, 71). This evidence concerns the gene CD274 and neoplasm.